Table 1.
Country | Number | Age range | Syndrome | Diagnostic criteria | Prevalence | Incidence | Reference |
---|---|---|---|---|---|---|---|
Germany | 126 | ≤ 15 years | MS | McDonald 2005 | 0.64 | Reinhardt et al. [45] | |
Netherlands | 86 | < 18 years | ADS | Krupp 2007 | – | 0.66 | Ketelsegers et al. [46] |
UK | 125 | 1-15 year | ADS | Krupp 2007 | – | 0.98 | Absoud et al. [47] |
Italy (Sardinia) | 21 | 0-18 years | MS | Krupp 2013 | 26.92 | 2.85 | Dell’Avvento et al. [48] |
USA | 81 | 0-18 years | ADS MS | Krupp 2007 | – | 1.66 0.51 | Langer-Gould et al. [49] |
Brazil | 125 | 0-18 years | MS | Krupp 2007 | 5.5% of MS population | Fragoso et al. [50] | |
Iran (Shiraz) | 88 | 1-18 years | ADS | – | 0.19 | Inaloo et al. [51] | |
Kuwait | 122 | < 18 years | MS | Krupp 2013 | 6.0 | 2.1 | Alroughani et al. [20] |
ADS acquired demyelinating syndromes